Enhancing_NN
effect_NN
of_IN
17_CD
beta-estradiol_NN
on_IN
human_JJ
NK_NN
cell_NN
activity_NN
._.

The_DT
in_FW
vitro_FW
effect_NN
of_IN
17_CD
beta-estradiol_NN
on_IN
NK_NN
activity_NN
was_VBD
studied_VBN
._.

The_DT
proliferation_NN
and_CC
NK_NN
activity_NN
of_IN
YT-N17_NN
-LRB-_-LRB-
a_DT
human_JJ
NK-like_JJ
cell_NN
line_NN
-RRB-_-RRB-
were_VBD
enhanced_VBN
by_IN
17_CD
beta-estradiol_NN
-LRB-_-LRB-
E2_NN
-RRB-_-RRB-
,_,
and_CC
the_DT
enhancement_NN
was_VBD
blocked_VBN
by_IN
tamoxifen_NN
-LRB-_-LRB-
Tx_NN
-RRB-_-RRB-
,_,
an_DT
antagonist_NN
of_IN
E2_NN
._.

On_IN
the_DT
contrary_NN
,_,
other_JJ
steroid_NN
hormones_NNS
such_JJ
as_IN
Tx_NN
,_,
progesterone_NN
,_,
and_CC
testosterone_NN
had_VBD
no_DT
effect_NN
._.

YT-N17_NN
contained_VBD
11.8_CD
fmol\/mg_NN
protein_NN
of_IN
estrogen_NN
receptor_NN
-LRB-_-LRB-
mean_NN
of_IN
two_CD
independent_JJ
assays_NNS
-RRB-_-RRB-
,_,
a_DT
value_NN
which_WDT
was_VBD
5-10-fold_RB
higher_JJR
than_IN
that_DT
of_IN
other_JJ
hematopoietic_JJ
cell_NN
lines_NNS
._.

An_DT
enhancement_NN
of_IN
NK_NN
activity_NN
by_IN
E2_NN
was_VBD
also_RB
seen_VBN
in_IN
large_JJ
granular_JJ
lymphocytes_NNS
obtained_VBN
from_IN
normal_JJ
subjects_NNS
,_,
and_CC
it_PRP
was_VBD
again_RB
suppressed_VBN
by_IN
Tx_NN
._.

These_DT
data_NNS
suggest_VBP
that_IN
E2_NN
is_VBZ
one_CD
of_IN
the_DT
activating_VBG
factors_NNS
for_IN
NK\/LGL_NN
cells_NNS
._.

